0002064835-26-000066.txt : 20260630 0002064835-26-000066.hdr.sgml : 20260630 20260630170221 ACCESSION NUMBER: 0002064835-26-000066 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260630 DATE AS OF CHANGE: 20260630 EFFECTIVENESS DATE: 20260630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Else Nutrition Holdings Inc. CENTRAL INDEX KEY: 0001807936 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-589187 FILM NUMBER: 261141426 BUSINESS ADDRESS: STREET 1: 1048 165TH STREET CITY: SURREY STATE: A1 ZIP: V4A 9A2 BUSINESS PHONE: 972 3-644-5095 MAIL ADDRESS: STREET 1: 1048 165TH STREET CITY: SURREY STATE: A1 ZIP: V4A 9A2 D 1 primary_doc.xml X0708 D LIVE 0001807936 Else Nutrition Holdings Inc. 1048 165TH STREET SURREY A1 BRITISH COLUMBIA, CANADA V4A 9A2 972 3-644-5095 BRITISH COLUMBIA, CANADA ASB Capital Inc. None Corporation true Hamutal Yitzhak 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Executive Officer Director Uriel Kesler 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Executive Officer Director Natie Zilberberg 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Executive Officer Michael Azar 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Executive Officer Reuben Halevi 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Executive Officer Yaki Lutski 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Director Satwinder Mann 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Director Eli Ronen 1048 165th Street Surrey A1 BRITISH COLUMBIA, CANADA V4A 9A2 Director Other $1,000,001 - $5,000,000 06b false 2025-11-24 true true true true true true Offering of convertible securities and warrants pursuant to a Convertible Security Funding Agreement dated 11-23-25 (the "Funding Agreement"), each convertible or exercisable for common shares false 0 2459028 936050 1522978 Total Remaining to be Sold includes anticipated proceeds from the fourth draw, plus the aggregate exercise price of warrants issued in the first, second and third draws and issuable in the fourth draw, under the Funding Agreement. false 1 0 0 0 true A portion of the net proceeds may be used for general working capital, including payments to officers and directors in the ordinary course, but proceeds are not earmarked for such payments. false Else Nutrition Holdings Inc. /s/ Hamutal Yitzhak Hamutal Yitzhak CEO 2026-06-30